-4- 
in light of NIH standards and procedures promoting maximum disclosure, 
these exemptions may significantly limit the applicability of the NIH 
Guidelines . 
Committee Advice 
Dr. Fredrickson, at the suggestion of Dr. Ancker-Johnson, asked all 
representatives to state their views on the Commerce Department Order. 
Committee members agreed that their views relate only to the health and 
safety aspects of the Order. 
The majority of Committee members were favorably disposed to the reinstate- 
ment of the Commerce Department Order because: (1) accelerated processing 
Involves no change in patent procedures that appears to be inimical to the 
public good; (2) it motivates compliance with the safety standards of the 
% 
NIH Guidelines by non-governmental ly funded domestic investigators during 
the period while national legislation is being considered; and (3) it 
encourages compliance with a set of recognized safety standards by foreign 
investigators who may not yet be subject to comparable standards in their 
own countries. Representatives from the following agencies so recommended: 
Veterans Administration, Nuclear Regulatory Commission, National Science 
Foundation, National Aeronautics and Space Administration, Energy Research 
and Development Administration, Food and Drug Administration, Center for 
Disease Control, Department of Defense, Department of Commerce, and 
Department of Agriculture. 
Subsequent to the meeting, representatives from the Departments of State 
and Transportation asked to be recorded in favor of this recommendation. 
[ 355 ] 
